Cargando…
BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593003/ https://www.ncbi.nlm.nih.gov/pubmed/36709159 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.016 |
| _version_ | 1784815056682221568 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9593003 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95930032022-11-14 BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2022-08 /pmc/articles/PMC9593003/ /pubmed/36709159 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.016 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 病例报告 BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 |
| title | BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 |
| title_full | BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 |
| title_fullStr | BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 |
| title_full_unstemmed | BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 |
| title_short | BVED方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 |
| title_sort | bved方案序贯自体造血干细胞移植治疗复发难治侵袭性淋巴瘤合并噬血细胞综合征2例 |
| topic | 病例报告 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593003/ https://www.ncbi.nlm.nih.gov/pubmed/36709159 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.016 |
| work_keys_str_mv | AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì AT bvedfāngànxùguànzìtǐzàoxuègànxìbāoyízhízhìliáofùfānánzhìqīnxíxìnglínbāliúhébìngshìxuèxìbāozōnghézhēng2lì |